Life expectancy means how many years you expect to live. Average life expectancy is approximately 78 years in the US but asbestos causing cancers like lung and mesothelioma cancer often decrease life span. Doctors estimate the life expectancy after checking the mesothelioma patient’s statistics. It is reported that mesothelioma tend to shorten life expectancy for approximately 17 years.
Life expectancy influential factors and mesothelioma
In some patient’s mesothelioma is diagnosed at the age of 65 but a few get diagnosed earlier than 49 years. Diagnoses at early stage means losing more years of life expectancy. Plenty of things influence on how long a person with mesothelioma can live including environmental and lifestyle factors. Research has revealed that three factors, which considerably impacts mesothelioma life expectancy is your –
- Overall health – Performance status is a scoring system used to determine overall health
- Cancer cell type – epithelial cell, sarcomatoid cells, and biphasic [mix of both cells]
- Cancer stage at diagnosis – 1st and 2nd stage is categorized as early diagnosis – 3rd and 4th stage are advanced phases
- Even gender and age play a role
Life expectance influenced by cancer stage
After mesothelioma is diagnosed, doctors focus on the development stage. It means how far the tumor has spread in the body. Cancer staging is crucial because the treatment plan is created on its basis. In the early stages chemotherapy and aggressive surgery is more affective and offers low survival benefits to late cancer stages.
Calculation of cancer stage is complex, especially asbestos related cancers. Accurate staging is crucial for planning surgery. Many people show mesothelioma symptoms at the 3rd or 4th stage, so a few qualify for surgery. Stage four mesothelioma symptoms get managed and eased with a hope to extend survival. Early patients are treated very aggressively with therapies, so as to extend their life expectancy for 5 years or more.
Several people suffering from asbestos-related cancer surpass average survival rates. Few people respond well to the treatment, while some have surprisingly potent immune system proficient to control cancer spreading expansively. Patients diagnosed with stage 3rd and 4th cancer have found to have lived for years during clinical trials.